60 Participants Needed

Mindful Self-Compassion for Lung Cancer

TJ
Overseen ByTimothy J Williamson, Ph.D., MPH
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how a mindfulness-based program can assist people with lung cancer who feel stigmatized. The program, Mindful Self-Compassion for Lung Cancer (MSC-LC), teaches mindfulness and self-compassion skills over 10 weeks. Researchers aim to determine if this program reduces stigma and enhances self-compassion compared to a waitlist group. Adults diagnosed with lung cancer who experience stigma and haven't recently completed a similar program or changed medications might be suitable for this trial. Participants will either join the program or receive mental health resources and participate later.

As an unphased trial, this study provides a unique opportunity to explore new methods for improving emotional well-being in those stigmatized by lung cancer.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are on antidepressant, anxiolytic, antipsychotic, or mood stabilizing medications, your dose should not have been changed in the 8 weeks before joining the study.

What prior data suggests that this mindfulness-based intervention is safe for adults with lung cancer?

Research has shown that mindful self-compassion (MSC) is safe and well-tolerated by patients. Studies have found that MSC helps people be kinder to themselves and reduces feelings of shame and distress. Participants in these studies did not report any serious side effects or harm. Instead, they experienced small-to-medium improvements in symptoms of depression, stress, and loneliness.

The Mindful Self-Compassion for Lung Cancer (MSC-LC) program tailors these techniques specifically for people with lung cancer. It focuses on helping them develop mindfulness and self-compassion skills. The goal is to reduce the stigma and stress often associated with a lung cancer diagnosis. This approach is gentle and supportive, making it a safe choice for many.12345

Why are researchers excited about this trial?

Researchers are excited about Mindful Self-Compassion for Lung Cancer (MSC-LC) because it offers a fresh approach to addressing the emotional and psychological challenges faced by patients. Unlike traditional treatments that focus on the physical aspects of lung cancer, MSC-LC is a group-based intervention that enhances mindfulness and self-compassion, aiming to reduce the stigma associated with the condition. This innovative method could provide an important complementary strategy alongside standard medical care, potentially improving the overall well-being and quality of life for patients.

What evidence suggests that Mindful Self-Compassion for Lung Cancer is effective in reducing stigma?

Research has shown that Mindful Self-Compassion (MSC) effectively increases self-kindness and reduces feelings of shame and distress in people with lung cancer. Early studies found that MSC helps individuals feel better about themselves and manage tough emotions. In this trial, participants in the Mindful Self-Compassion for Lung Cancer (MSC-LC) arm will engage in a program specifically designed to reduce stigma, the negative feeling associated with having lung cancer. By teaching mindfulness and self-compassion skills, this program aids in managing emotions and improving emotional well-being. Initial feedback from participants in similar programs indicates they feel less stigmatized and more compassionate toward themselves.12346

Who Is on the Research Team?

TJ

Timothy J Williamson, Ph.D., MPH

Principal Investigator

Loyola Marymount University

Are You a Good Fit for This Trial?

This trial is for adults with lung cancer who feel stigmatized because of their diagnosis. Participants will be randomly assigned to either learn mindfulness and self-compassion skills in a virtual group setting over 10 weeks or placed on a waitlist while receiving standard mental health resources.

Inclusion Criteria

I have been diagnosed with lung cancer, confirmed by my doctor.
Able to read and respond to questions in English
Endorses elevated levels of lung cancer stigma (scores >37.5 on the Lung Cancer Stigma Inventory)

Exclusion Criteria

I haven't started or changed any mental health meds in the last 8 weeks.
I understand the study procedures and consent process and do not have significant personality issues that would interfere with participation.
I have completed a mindfulness or meditation course in the past year.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Mindful Self-Compassion for Lung Cancer (MSC-LC) intervention, a 10-week, virtually-delivered, group-based psychosocial intervention focused on mindfulness and self-compassion skills

10 weeks
Weekly virtual sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 weeks
Assessments at 5 weeks and 16 weeks post-intervention

What Are the Treatments Tested in This Trial?

Interventions

  • Mindful Self-Compassion for Lung Cancer (MSC-LC)
Trial Overview Researchers are testing a new program called Mindful Self-Compassion for Lung Cancer (MSC-LC) against an enhanced standard of care. They want to see if MSC-LC can help reduce feelings of stigma and increase self-kindness among lung cancer patients.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Self-Compassion for Lung Cancer (MSC-LC)Experimental Treatment1 Intervention
Group II: Enhanced standard of care with waitlistActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Loyola Marymount University

Lead Sponsor

Trials
9
Recruited
8,800+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

In a study of 88 couples facing lung cancer, both patients and their spouses showed that higher levels of self-compassion were significantly associated with lower psychological distress, indicating that self-compassion may be a key factor in coping with cancer-related stress.
The study suggests that mindfulness and self-compassion not only benefit individuals but may also enhance communication within couples, highlighting the potential for mindfulness-based interventions to improve couple dynamics during cancer treatment.
Are Mindfulness and Self-Compassion Related to Psychological Distress and Communication in Couples Facing Lung Cancer? A Dyadic Approach.Schellekens, MPJ., Karremans, JC., van der Drift, MA., et al.[2020]
In a study involving 979 participants from an online health community, those who engaged in Loving Kindness Meditation (LKM) immediately reported significant improvements in perceived stress, self-compassion, and social connectedness compared to those who started the practice after a 3-week delay.
The effectiveness of LKM increased with more frequent practice, suggesting that regular engagement in this mind-body approach can enhance emotional resilience during challenging health journeys.
A Randomized Trial of 21 Days of Loving Kindness Meditation for Stress Reduction and Emotional Well-being Within an Online Health Community for Patients, Family, and Friends Experiencing a Cancer Health Journey.Telke, S., Leininger, B., Hanson, L., et al.[2022]
Mindfulness-based therapy (MBT) significantly reduces anxiety, depression, fear of recurrence, and fatigue in breast cancer patients, based on a meta-analysis of seven studies involving 951 participants.
MBT also improves emotional well-being, physical function, and physical health in these patients, suggesting it could be a valuable complementary treatment alongside standard care.
Effects of mindfulness-based therapy for patients with breast cancer: A systematic review and meta-analysis.Zhang, J., Xu, R., Wang, B., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39868945/
Mindful self-compassion for lung cancer (MSC-LC) - PubMedMindful self-compassion (MSC) is an empirically supported intervention demonstrated to increase self-compassion and reduce feelings of shame and distress in ...
Adapting and Testing a Novel Self-Compassion ...This is a pilot trial examining the feasibility, acceptability, and preliminary efficacy of MSC-LC, compared to waitlist control condition. The central ...
Mindful self-compassion for lung cancer (MSC-LC)Mindful self-compassion (MSC) is an empirically supported intervention demonstrated to increase self-compassion and reduce feelings of shame and ...
Mindful self-compassion for lung cancer (MSC-LC ...Mindful self-compassion (MSC) is an empirically supported intervention demonstrated to increase self-compassion and reduce feelings of shame and ...
Mindful Self-Compassion for Lung Cancer (MSC-LC)The purpose of this research study is to evaluate the effectiveness of Mindful Self-Compassion for Lung Cancer (MSC-LC) program in helping patients respond to ...
Mindful self-compassion for lung cancer (MSC-LC)Mindful self-compassion for lung cancer (MSC-LC): Incorporating perspectives of lung cancer patients, clinicians, and researchers to create an ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security